paper_id,claim,figure_id,title,caption,local_image_path,url
PMC5778176,No difference in the final titrated dose was observed in patients who started treatment with Gla-300 versus patients who started treatment with Gla-100 (LS mean 0.43 units per kilogram vs 0.44 units per kilogram; P = 0.77) (Fig. 1).,PMC5778176_figure_1,Fig. 1.,Daily titrated basal insulin dose (LS means) for insulin-naive patients starting treatment with insulin glargine at a strength of 100 units per milliliter (Gla-100) or insulin glargine at a strength of 300 units per milliliter (Gla-300),./data/PMC5778176/images/figure_1.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60d3/5778176/bfae790d6d04/12325_2017_651_Fig1_HTML.jpg
PMC5778176,"Open in a new tab
Daily titrated basal insulin dose (LS means) for insulin-naive patients starting treatment with insulin glargine at a strength of 100 units per milliliter (Gla-100) or insulin glargine at a strength of 300 units per milliliter (Gla-300)After other covariates had been controlled for, the daily dose of basal insulin was significantly lower after switching to treatment with Gla-300 (Fig. 2), with the adjusted difference between the preswitch and postswitch values being −0.15 units per kilogram (95% CI −0.28 to −0.02 units per kilogram; P = 0.02).",PMC5778176_figure_2,Fig. 2.,Preswitch and postswitch daily basal insulin dose for patients switching to treatment with insulin glargine at a strength of 100 units per milliliter (Gla-100) or insulin glargine at a strength of 300 units per milliliter (Gla-300),./data/PMC5778176/images/figure_2.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60d3/5778176/a6a4a923726c/12325_2017_651_Fig2_HTML.jpg
PMC5778176,"After other covariates had been controlled for, the daily dose of basal insulin was significantly lower after switching to treatment with Gla-300 (Fig. 2), with the adjusted difference between the preswitch and postswitch values being −0.15 units per kilogram (95% CI −0.28 to −0.02 units per kilogram; P = 0.02).",PMC5778176_figure_2,Fig. 2.,Preswitch and postswitch daily basal insulin dose for patients switching to treatment with insulin glargine at a strength of 100 units per milliliter (Gla-100) or insulin glargine at a strength of 300 units per milliliter (Gla-300),./data/PMC5778176/images/figure_2.jpg,https://cdn.ncbi.nlm.nih.gov/pmc/blobs/60d3/5778176/a6a4a923726c/12325_2017_651_Fig2_HTML.jpg
